Nutriment preparation

Food or edible material: processes – compositions – and products – Products per se – or processes of preparing or treating... – Fat or oil is basic ingredient other than butter in emulsion...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

426606, A23D 9007

Patent

active

054927137

DESCRIPTION:

BRIEF SUMMARY
BACKGROUND OF THE INVENTION

The present invention concerns a nutriment preparation for humans and animals comprising an energy substrate which is suited in particular for uraemic patients and for clinical nutrition.
Patients who must be nourished clinically often display a poor standard of nutrition such as that obtaining in the case of severe trauma, for example severe and extensive burns, operative trauma, severe physical injuries, different forms of cancer or sepsis. In such conditions, the metabolism picture is complicated.
In the metabolism of the body a number of metabolites which are subject to further oxidation and thereby produce different amounts of energy are synthesized from carbohydrates and fats. The ketone bodies which represent important alternative energy substrates for the body are examples of such metabolites. In the condition of hunger they are created in large quantities, and in the case of a prolonged hunger condition they become more important than glucose as an energy source. The possibility of utilizing ketone bodies to prevent the damaging decomposition (catabolism) of muscular protein for gluconeogenesis thereby reduces the loss of valuable body protein and thus exerts an energy-saving effect.
In the peripheral protein depots (muscles) mainly the branched-chain amino acids leucine, isoleucine and valine, in the main leucine, are oxidized, which means that in these patients the pool of branched-chain amino acids is gradually exhausted, which in turn results in reduced protein synthesis in the liver.
Ketone bodies have thus become increasingly interesting as an energy substrate both in enteral and parenteral nutrition, beyond their current administration in dialysis patients resp. patients displaying restricted kidney function.
Numerous experiments have already been conducted to find a method by which ketone bodies and similar substances may be effectively administered to the body. The branched-chain keto-acids, in particular ketoleucine, ketoisoleucine and ketovaline, are of special interest in this regard.
However, for a number of reasons the possibility of administering keto-acids is limited. They are practically not processable in aqueous solution, since they display very minimal stability and, moreover, they also cause very considerable strain. In addition, they must be administered in the form of salts, which entails the risk that excessive quantities of cations, for example sodium cations and potassium cations, are ingested during their administration. Furthermore, keto-acids and their salts are soluble in water and thereby raise the osmotic pressure of the nutriment, which causes the corresponding deleterious effects, such as too rapid passage through the bowels and diarrhea.
A circumvention of these problems is achieved by the somewhat more stable branched-chain .alpha.-hydroxy acids, which, however, were initially only administered as unazotized amino acid substitutes. According to the PCT-Application WO 90/02547, .alpha.-hydroxy acids and their pharmaceutically acceptable metal salts are used as precursors of the branched-chain keto-acids. These .alpha.-hydroxy acids are used metabolically as an energy substrate in enteral and parenteral nutrition after respective metabolization.
In the EP 0 367 734 energy substrates for clinical nutrition were used, which contain at least one ester of glycerine and at least one branched-chain hydroxycarbon acid. L-.alpha.-hydroxyisocapronic acid, .alpha.-hydroxy-.beta.-methylvaleric acid and L-.alpha.-hydroxyisovaleric acid were named as examples of such hydroxycarbon acids.
The use of triglycerides with less calories in nutriments is proposed in the PCT-Application WO 91/03944, whereby the calory ingestion is to be reduced simultaneously with nutriment ingestion. In the triglycerides designed for this purpose, the hydroxy groups in position 1 and 3 of the glycerol are estered with saturated long-chain fatty acids (16-40 carbon atoms) and the hydroxy group in position 2 of the glycerol is estered with a short-chain acid (2-10 carbon at

REFERENCES:
patent: 3579548 (1971-05-01), Whyte
Patton 1976 Biomedical Aspects of Lactation Pergamon Press New York pp. 88-91.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Nutriment preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nutriment preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nutriment preparation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1354817

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.